Chronic nonbacterial prostatitis. Other inflammatory diseases of prostate
Conditions
Interventions
Intervention 1: Control group: Patients with chronic nonbacterial prostatitis use of Terazosin tablets (2 mg) and placebo capsules (50 mg) on a daily basis for the first week, followed by the daily us
Treatment - Drugs
Control group: Patients with chronic nonbacterial prostatitis use of Terazosin tablets (2 mg) and placebo capsules (50 mg) on a daily basis for the first week, followed by the daily use of 100 mg plac
Intervention group: Patients with chronic nonbacterial prostatitis use of terazosin tablets (2 mg) and pregabalin capsules (50 mg) on a daily basis for the first week, followed by the daily use of 100
Sponsors
Vice Chancellor for Research of Arak University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to 139 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Age over 18 years; 2) no prior history of other urinary system disorders such as urinary tract stones, neurogenic bladder, and urinary infections; 3) no history of major underlying diseases such as cirrhosis, renal failure, diabetes, or hypertension; 4) normal levels of urine, fasting blood sugar (FBS), and creatinine; 5) normal results on the first neurological examination of the perineal area, lower limbs, lower limb reflexes, and bulbocavernosus reflex; 6) no use of other medicines; 7) no signs of psychological disorders; 8) confirmed diagnosis of chronic prostatitis; 9) non-sensitivity to anti-epileptic drugs, pregabalin, thiazolidinediones, or other anti-diabetic agents. Exclusion criteria: 1) Unwillingness to continue the study, and 2) major side-effects due to the use of medications.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rang of pain. Timepoint: 6 weeks after therapy. Method of measurement: NIH-CPSI scoring system, Scoring from 0 to 21. | — |
Secondary
| Measure | Time frame |
|---|---|
| Urinary symptoms. Timepoint: 6 weeks after therapy. Method of measurement: NIH-CPSI scoring system, Scoring from 0 to 10. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Sirous
Arak University of Medical Sciences
Outcome results
None listed